India’s drug quality standards have come under increased scrutiny at home and overseas in recent years after locally made cough syrups were linked to the deaths of children in India and also in countries including Gambia and Uzbekistan
India’s drug quality standards have come under increased scrutiny at home and overseas in recent years after locally made cough syrups were linked to the deaths of children in India and also in countries including Gambia and Uzbekistan
<iframe src="https://hindustansphere.com/embed/cluster/8da6e0ce99bf485fa10e985843f2c7f48b2094de" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="India orders Sun Pharma to halt eye-care drug production at plant after quality lapses"></iframe>
India’s drug quality standards have come under increased scrutiny at home and overseas in recent years after locally made cough syrups were linked to the deaths of children in India and also in countries including Gambia and Uzbekistan
India’s drug quality standards have come under increased scrutiny at home and overseas in recent years after locally made cough syrups were linked to the deaths of children in India and also in countries including Gambia and Uzbekistan
